How many insider declarations has Martine Rothblatt filed?

Martine Rothblatt has filed 2 public insider declarations with SEC (Form 4).

What is Martine Rothblatt's role?

Martine Rothblatt's reported role is not specified by the regulator across the filings.

Which companies does Martine Rothblatt report trades for?

Martine Rothblatt reports trades for UNITED THERAPEUTICS CORPORATION.

← Executives ★ Sign in to follow

MR

Martine Rothblatt

OFFICERF

·SEC (Form 4)

UNITED THERAPEUTICS CORPORATION

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the detailed record of transactions filed by Martine Rothblatt. Insider active across 1 company, notably UNITED THERAPEUTICS CORPORATION. Aggregated, 2 disclosures have been recorded. Activity tracked since 1 July 2026. The latest transaction was filed on 3 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Martine Rothblatt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

UNITED THERAPEUTICS CORPORATION (US)

申报2 总计

●

MARTINE ROTHBLATT

Director, Officer高管2026年8月3日UNITED THERAPEUTICS CORPORATION

US$1亿31来源 ↗

199,500 股@ US$517.710.40% mcap47.4% 占其流量CommonSEC144:0001950047-26-007555

●